Free Subscription to CFO Magazine

Mergers and Acquisitions

You are here: Home : Topics A-Z : Mergers and Acquisitions

Follow this topic

  • Buying Time

    Will swallowing Wyeth cure Pfizer? February 4, 2009

  • Citi's Amazing Smith Barney Gain

    Citi's recorded gain from the Morgan Stanley joint venture deal is more than double its cash outlay thanks to a new accounting rule. February 3, 2009

  • Deals: High on Drugs

    In our M&A roundup for the final week of January, two huge drug company acquisitions pep up merger activity in an otherwise dreary month. February 3, 2009

  • The Big Owe

    Rio Tinto's hefty debts have pushed it to seek investment from China. February 3, 2009

  • Here Comes the Sun

    Inventive and opportunistic M&A may get more opportunities in turbulent times, but CFOs should prepare for questioning from an investor community wary of surprises. February 2, 2009

  • Forced to the Altar

    This year's big deals could transform their industries. February 2, 2009

  • You Oughta Plea in Pictures

    To make a stronger business case, put away the spreadsheets and get out your pencil. February 1, 2009

  • That Was the Year that Wasn't — for M&A

    In 2008, nearly every global and U.S. category was off, according to a William Blair report, and 2009 looks little better. An exception: U.S. deals under $50-million in value. January 28, 2009

  • Deals: Mid-sized M&A Rules the Week

    In our M&A Roundup for the week ending Jan. 25, while Pfizer-Wyeth was being nailed down quietly, only smaller transactions took shape, led by a $584m combination of software companies Autonomy Corp. and Interwoven Inc. January 26, 2009

  • Taking Something for It

    Pfizer, the world's biggest drugmaker, wants to get even bigger by taking over Wyeth, a rival. January 26, 2009

Related White Papers

» More Related White Papers

advertisement

Business Solutions Center

» More Business Solutions Center Links

advertisement